SEC Form D · Amendment · filed June 22, 2015
Genomind, Inc
Industry
Other Health Care
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Joseph E. Anton · Boston, MADirectorThomas E. Hess · King of Prussia, PAExecRina E. Wolf · Valencia, CADirectorGloria E. Nuss · Norfolk, VAExecTheresa E. Sexton · Nashville, TNDirectorJohn E. Chadwick · Nashville, TNDirectorBeth E. Dozoretz · Norfolk, VAExec · DirectorMichael I. Koffler · King of Prussia, PAExec · Director · PromoterRonald I. Dozoretz · Norfolk, VAExec · Director · PromoterStephen E. Haller · Norfolk, VAExecPCM Capital Select Managers Fund LLC · Kansas City, MODirectorPhalanx Capital GP, LLC · Chicago, ILExec · DirectorR. L. Priest, Jr · Williamsburg, VADirectorRail-Splitter Capital Management, LLC · Chicago, ILDirectorHoward S. Silverman · OMAHA, NEExec · Director · PromoterRobert A. Dean · OMAHA, NEExec · DirectorDouglas L. Dethy · New York, NYExec · DirectorDouglas B. Dunn · Houston, TXExec · Director · PromoterPCM Capital Managed Equity Fund I LLC · Kansas City, MOExec · Director · PromoterAugusto Alvarez · Santa Fe, O5ExecDavid Riker · New York, NYDirectorJack Weiss · New York, NYExec · Director · PromoterJonathan Budd · DEL MAR, CAExecDan A. Westbrook · Oklahoma City, OKDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗